Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Genetic analysis is crucial for diagnosing and managing cerebral arteriopathy.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Early diagnosis and treatment are crucial for managing Berardinelli–Seip syndrome.

Baricitinib shows promise in treating severe hair loss.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Bee venom can help stem cells promote hair growth.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

People with primary cicatricial alopecia have a higher risk of heart disease and stroke.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

The M-type is the most common form of male hair loss, and the BASP-classification is easy for different medical professionals to use.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

C-scores can help predict gain-of-function and loss-of-function mutations.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.